News of the day
NUVO RESEARCH PROVIDES WF10 LICENSING AND DEVELOPMENT UPDATE
Mississauga, Ontario, Canada - November 11, 2009 - Nuvo Research Inc. (TSX: NRI), a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be...
more
Mobidiag Launches Rapid DNA Microarray Technology for Diagnostics of Bone and Joint Infections
Birmingham, United Kingdom, November 11, 2009 - Finnish molecular diagnostics company Mobidiag releases rapid microarray solution for identifying bacteria responsible for bone and joint infections (BJIs). Enhancing the test panel with targets such as Kingella kingae and Propionibacterium acnes adds new capabilities to Mobidiag's assay. Prove-it(TM) Sepsis application for Bone and Joint infections includes simultaneous identification of altogether 64 bacterial targets in a single assay thus...
more
Foamix Extends Collaboration with Galderma
Rehovot (Israel), November 3, 2009 -- Foamix Ltd, a global leader in the development of dermatological foam medications today announced that the company has extended its agreement with Galderma to develop an innovative medicated foam for an additional dermatological indication. This new treatment contains a novel drug for the therapy of certain skin diseases.
more
Industry news search
Recent news
To keep up to date with news from this category use our 
XOFT SHOWCASES MULTI-DISCIPLINARY ELECTRONIC BRACHYTHERAPY CANCER TREATMENT PLATFORM AT ASTRO
CHICAGO, Nov. 2, 2009 - Xoft, Inc., developer of the Axxent